Ahmad A. Tarhini
Advanced Dermatology(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Immunotherapy and Immune Responses, Cutaneous Melanoma Detection and Management, Radiomics and Machine Learning in Medical Imaging
Most-Cited Works
- → Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain(2018)1,297 cited
- → Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination(2016)1,087 cited
- → Prognostic significance of autoimmunity during treatment of melanoma with interferon(2011)509 cited
- → Immunotherapy of cancer in 2012(2012)431 cited
- → Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC)(2021)418 cited
- → Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial—ECOG-ACRIN EA6134(2022)410 cited
- → Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma(2015)382 cited
- → Ipilimumab Plus Sargramostim vs Ipilimumab Alone for Treatment of Metastatic Melanoma(2014)352 cited
- → Immune Monitoring of the Circulation and the Tumor Microenvironment in Patients with Regionally Advanced Melanoma Receiving Neoadjuvant Ipilimumab(2014)309 cited
- → Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study(2019)271 cited